An older alkylating-type chemotherapy for blood disorders

Pipobroman

An old chemotherapy medicine, now obsolete, once used to control polycythaemia vera and chronic myeloid leukaemia.

What is Pipobroman?

Pipobroman is an old alkylating-type chemotherapy medicine taken by mouth that was used to control polycythaemia vera (a condition where the body makes too many blood cells) and chronic myeloid leukaemia. Its dominant risk is bone-marrow suppression, meaning it lowers the body's blood cells and can cause infections, bleeding and tiredness. Like other chemotherapy of its type, it can also carry a long-term risk of leukaemia. It is now obsolete and has been replaced by safer, more effective modern treatments.

Education and reference only. This is a plain-language guide to Pipobroman — it deliberately contains no doses. Doses depend on the person, the brand and the reason for treatment, and belong with your prescriber. Always check the BNF, the product labelling (SmPC) and follow medical advice.

Brands: Vercyte (historical)
Pipobroman (Alkylating-type chemotherapy agent (historical)) — Meds Global Health reference card with 2D molecular structure
Pipobroman — Alkylating-type chemotherapy agent (historical). The image shows the active ingredient's 2D molecular structure.

What it is

Pipobroman is a chemotherapy medicine that acts in a way similar to alkylating agents, damaging the genetic material in cells so they cannot multiply. It was used to control polycythaemia vera, a condition in which the bone marrow makes too many red blood cells, and at times chronic myeloid leukaemia. It was taken by mouth. It is now considered obsolete, having been replaced by treatments that are safer and more effective, so it is essentially of historical interest in the UK today.

How it works

Pipobroman works on the bone marrow to slow down the overproduction of blood cells that occurs in conditions such as polycythaemia vera. It does this by interfering with the genetic material inside dividing cells, similar to alkylating chemotherapy, so they cannot keep multiplying. By dampening this overproduction it helps bring abnormal blood counts back towards normal. However, because it acts on dividing cells in general, it also suppresses healthy bone marrow, which is why it lowers normal blood cells and needs careful blood monitoring.

Company & origin

Originated / developed by: Generic (obsolete).

An old chemotherapy medicine, no longer in routine use, given by mouth to control blood disorders such as polycythaemia vera.

Practical use

How to take Pipobroman

General, dose-free guidance — always follow your prescriber's and the leaflet's specific instructions.

  • It was taken by mouth exactly as directed by the specialist team.
  • Regular blood tests are essential to watch the bone marrow and blood counts.
  • Report signs of infection, such as fever, or any unusual bruising or bleeding, straight away.
  • Tell the team about all other medicines, as chemotherapy can interact with many of them.
  • Use only under close specialist supervision; it is now an obsolete treatment replaced by modern medicines.

Weighing it up

Advantages & disadvantages of Pipobroman

Advantages

  • Could be taken by mouth to control overproduction of blood cells when it was in use.
  • Helped manage polycythaemia vera and related blood disorders before modern treatments.
  • Part of the historical group of cancer medicines that informed later, safer treatments.

Disadvantages

  • Suppresses the bone marrow, lowering blood cells and raising the risk of infection, bleeding and tiredness.
  • Can carry a long-term risk of causing leukaemia or other cancers.
  • Now obsolete, having been replaced by safer and more effective modern treatments.

Practical use

Good to know

The most important thing about pipobroman is that, like other chemotherapy of its kind, it suppresses the bone marrow, which makes the blood cells that fight infection, carry oxygen and help clotting. This can cause low blood counts leading to infections, unusual bruising or bleeding, and tiredness, so regular blood tests are essential. Alkylating-type chemotherapy can also carry a long-term risk of causing leukaemia or other cancers, which is an important reason it has been replaced by safer options. Because the medicine is now obsolete and better treatments exist, you would not expect to be offered it today; it is described here for completeness. Any chemotherapy of this kind is only ever used under close specialist supervision.

Who should not take it / use with caution

  • People who have had a serious allergic reaction to it should not take it.
  • It is unsuitable for people whose bone marrow is already severely suppressed.
  • It is avoided in pregnancy because chemotherapy of this kind can harm an unborn baby.

Monitoring

  • Regular blood counts to watch for bone-marrow suppression.
  • Watching for signs of infection, bruising or bleeding.
  • Reviewing how the blood disorder responds to treatment over time.

Side effects

  • A drop in blood cells (bone-marrow suppression), causing infections, bruising, bleeding or tiredness.
  • Nausea or other stomach upset.
  • A long-term risk of developing leukaemia or other cancers.
  • Effects on fertility, which the specialist team would discuss before treatment.

Key interactions

  • It can add to the bone-marrow-lowering effect of other chemotherapy or radiotherapy.
  • Live vaccines are generally avoided during treatment because the immune system is weakened.
  • Tell the team about all medicines, as chemotherapy can interact with many of them.

Available as: Tablets taken by mouth (historical).

Answers

Pipobroman: frequently asked questions

What was pipobroman used for?

It was an old chemotherapy taken by mouth to control polycythaemia vera, where the body makes too many blood cells, and at times chronic myeloid leukaemia. It is now obsolete.

Why does it lower blood counts?

Like other chemotherapy of its kind, it acts on dividing cells in the bone marrow, which makes blood cells, so it can cause low counts and a risk of infection, bleeding and tiredness.

Is it still used?

No. It has been replaced by safer and more effective modern treatments, so it is essentially of historical interest.

Does it have long-term risks?

Alkylating-type chemotherapy can carry a long-term risk of causing leukaemia or other cancers, which is one reason it is no longer preferred.

How was it taken?

It was taken by mouth as tablets, under the close supervision of a specialist team with regular blood tests.

Authoritative sources

  • BNF
  • NICE CKS

Building a medicines information resource?

We create evidence-led, dose-free drug and formulary references for teams.

☎ Call Get a Proposal